Patients with pediatric non-infectious uveitis (NIU) who achieved remission on adalimumab (Humira) had lower recurrence rates ...

Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms ...

Tom Fletcher revealed earlier this week that he had been rushed to hospital after suffering a nasty uveitis flare up which ...

Maharashtra Chief Minister Devendra Fadnavis on Sunday lauded the Rashtriya Swayamsevak Sangh (RSS) workers for their efforts ...

In an Instagram story the former McFly singer and Strictly star, said he'd suffered a flare-up of a long-term health ...

Doheny Eye Institute has been a pioneering leader in vision research, dedicated to the conservation, improvement and restoration of ...

Tom Fletcher recently took to social media on March 31 to share a health update. Fletcher was rushed to the hospital earlier this week for a flare-up from an autoimmune condition called Uveitis, which ...

Oculis has significant longer-term potential. However, it remains a high-risk investment given its clinical stage status, and ...

Behçet's disease ... uveitis, retinal vasculitis and vascular, neurological and gastrointestinal involvement. However, some patients still have refractory disease, relapse, sight-threatening eye ...

Virtu Financial LLC bought a new stake in shares of Skye Bioscience, Inc. (NASDAQ:SKYE – Free Report) during the 4th quarter, HoldingsChannel reports. The firm bought 10,142 shares of the company’s ...

Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) has been given a consensus rating of “Buy” by the seven ratings firms that are currently covering the firm, MarketBeat.com reports. Seven ...